Menu
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
Investors continue to roll money out of stocks and stock funds and into bond funds, but many might not understand the risks in that retirement strategy. More
Selling out of a position in dividend stocks, even with a 1,000% gain, is a tricky if you believe in the business and its future potential. Here's why. More
This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. More
With the stock market hitting all-time highs there aren't many stocks with low valuations today. But here are 13 dividend stocks to consider for your portfolio More
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. More
Sponsored By:
Sponsored By:
